Understanding PI3K signalling in colorectal cancer: from function to therapy

Michelle Palmieri(Walter and Eliza Hall Institute of Medical Research)
Minerva Access (University of Melbourne)
January 1, 2016
Cited by 0

Related Papers

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Cancer Discovery|2023|91
PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer
|Molecular & Cellular Proteomics|2023|8
Supplementary Data Table S6 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Unknown|2024|0
Supplementary Data Figure S1 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Unknown|2024|0
Supplementary Data Figure S27 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Unknown|2024|0